Myopridin (Pridinol Mesilate)

Myopridin (pridinol mesilate) is used as a centrally acting muscle relaxant to alleviate conditions involving involuntary muscle contraction.

• Muscle spasm: provides symptomatic relief of acute skeletal muscle spasm.
• Tension‑type headache: reduces associated muscular tension contributing to headache pain.
• Post‑operative discomfort: eases residual muscle tightness after surgical procedures.

• Pridinol mesilate exerts its effect by acting on central nervous system pathways that modulate muscle tone. It is thought to depress spinal reflexes and alter neurotransmitter activity, leading to reduced skeletal muscle hyperexcitability without directly affecting the neuromuscular junction.

Adverse reactions may occur with oral pridinol mesilate.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dry mouth: reduced salivation causing throat discomfort.
• Nausea: upset stomach or urge to vomit.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Gastrointestinal upset: abdominal discomfort or mild diarrhea.
• Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Hepatic dysfunction: jaundice, elevated liver enzymes.
• Severe hypotension: marked drop in blood pressure with fainting.
• Cardiac arrhythmia: irregular heart rhythm requiring medical attention.

Before using Myopridin, consider the following safety measures.

• Assess renal function: adjust use if severe impairment is present.
• Review hepatic status: monitor liver enzymes during prolonged therapy.
• Avoid operating machinery: drowsiness may impair alertness.
• Limit alcohol intake: combined CNS depression can increase sedation.
• Pregnant or breastfeeding women: use only if clearly indicated by a healthcare professional.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Pridinol mesilate may interact with other medicines.

Major Interactions (Avoid)

• CNS depressants: additive sedation with benzodiazepines or barbiturates.
• Alcohol: enhances drowsiness and impairment.
• Antihistamines: increased risk of sedation.
• MAO inhibitors: potential for exaggerated hypotensive effects.
• Anticholinergic agents: may worsen dry‑mouth symptoms.

Moderate Interactions (Monitor Closely)

• CYP450 substrates: possible alteration of metabolism for drugs such as warfarin.
• Antihypertensives: monitor blood pressure for additive lowering.
• Anticoagulants: watch for changes in bleeding risk.
• Diuretics: assess electrolyte balance.
• Selective serotonin reuptake inhibitors: observe for increased central side effects.